Douglas L Braunstein
CIK 1495110 · See Remarks · last filed 2026-08-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$214.33M
Companies
10
Total Filings
47
Lifetime Open-Market Net
$75.64M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TALK | Director | 0 | $5.25 | $0 | $0 | 1 | 2026-08-17 |
| Talkspace, Inc. (TALKW) Delisted | Director | 3,088,020 | $0.00 | $618 | $53.02M | 15 | 2026-06-03 |
| CANTALOUPE, INC. (CTLP) Delisted | 10%+ Owner | 12,188,827 | $11.20 | $136.51M | $1.95M | 2 | 2022-05-25 |
| Hudson Executive Investment Corp. III (HIIIU) Delisted | President, Chairman | — | $10.08 | — | $0 | 1 | 2021-04-14 |
| CANTALOUPE, INC. (USAT) Delisted | 10%+ Owner | 11,036,174 | $12.16 | $134.20M | $0 | 2 | 2020-07-02 |
| Cardtronics plc (CATM) Delisted | Director | 8,135,021 | $39.01 | $317.35M | $0 | 1 | 2020-04-02 |
| Corindus Vascular Robotics, Inc. (CVRS) Delisted | Director | 14,341,764 | — | — | $4.00M | 11 | 2019-10-09 |
| CANTALOUPE, INC. (USATP) Delisted | 10%+ Owner | 10,140,172 | — | — | $24.74M | 1 | 2019-09-26 |
| EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Director | 810,365 | $2.14 | $1.73M | -$8.06M | 7 | 2019-09-19 |
| JPM | Chief Financial Officer | 603,836 | $354.95 | $214.33M | $0 | 5 | 2013-01-04 |
Recent Filings · Page 5 of 5
47 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-01-06 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-07-06 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-01-04 | JPM | Gift (G) | — | $0 | EDGAR |
| 2012-01-20 | JPM | Grant (A) | — | $0 | EDGAR |
| 2012-01-18 | JPM | Tax (F) | −92,149 | -$3.27M | EDGAR |
| 2011-01-21 | JPM | Grant (A) | — | $0 | EDGAR |
| 2011-01-18 | JPM | Tax (F) | −151,966 | -$6.77M | EDGAR |
Showing 41–47 of 47
Prev
Page 5 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.